This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
A retrospective study demonstrated slightly elevated baseline fasting plasma glucose levels to be a robust marker of incident diabetes risk, even when those levels fell within the normal range.
Medscape Medical News